INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 439m ago
HOUSE PTR39m ago
SEC 13F38m ago
ROBINHOOD CHAIN38m ago
HOUSE PTR/Partial saleVerified data

Josh Gottheimer sold INSM

Joint · INSMED Inc · Insmed Incorporated - Common Stock

Side
SELL
Value range
$1,001 – $15K
Shares
Not disclosed
Price
—
Executed
Jun 10, 2026
Disclosed
Jul 7, 2026
Disclosure timeline27 days from execution to publication · legal deadline 45 days
Jun 10 executedJul 7, 2026 disclosed

INSM · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
25/ 100 · ROUTINE
Methodology →
  • Transaction type+10 / 20

    Partial sale

  • Relative size+2 / 25

    Disclosed range starting at $1K

  • Filing timing0 / 15

    Disclosed 27 days after execution (STOCK Act deadline: 45)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering+5 / 15

    1 other actor traded the same direction within 14 days

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · INSM

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    HP
    Hudson PaulDirector
    INSMINSMED Inc
    Grant or award
    		A—
    6,139 sh
    		Oct 19, 2026Oct 20, 2026
    traded Oct 19, 2026
    		+1dSEC FORM 4

    Evidence

    9
    KU
    Koppikar UtpalDirector
    INSMINSMED Inc
    Grant or award
    		A—
    6,139 sh
    		Oct 19, 2026Oct 20, 2026
    traded Oct 19, 2026
    		+1dSEC FORM 4

    Evidence

    0
    FD
    Flammer Martina M.D.Chief Medical Officer
    INSMINSMED Inc
    Option exercise · 10b5-1 plan
    		M—
    8,895 sh
    		Aug 6, 2026Aug 7, 2026
    traded Aug 6, 2026
    		+1dSEC FORM 4

    Evidence

    11
    FD
    Flammer Martina M.D.Chief Medical Officer
    INSMINSMED Inc
    Open-market sale · 10b5-1 plan
    		SELL$1.13M
    8,895 sh
    		Aug 6, 2026Aug 7, 2026
    traded Aug 6, 2026
    		+1dSEC FORM 4

    Evidence

    15
    FD
    Flammer Martina M.D.Chief Medical Officer
    INSMINSMED Inc
    Open-market sale · 10b5-1 plan
    		SELL$2.37M
    18.3K sh
    		Aug 6, 2026Aug 7, 2026
    traded Aug 6, 2026
    		+1dSEC FORM 4

    Evidence

    4
    FD
    Flammer Martina M.D.Chief Medical Officer
    INSMINSMED Inc
    Option exercise · 10b5-1 plan
    		M—
    18.3K sh
    		Aug 6, 2026Aug 7, 2026
    traded Aug 6, 2026
    		+1dSEC FORM 4

    Evidence

    0
    FD
    Flammer Martina M.D.Chief Medical Officer
    INSMINSMED Inc
    Option exercise · 10b5-1 plan
    		M$230K
    8,895 sh
    		Aug 6, 2026Aug 7, 2026
    traded Aug 6, 2026
    		+1dSEC FORM 4

    Evidence

    6
    FD
    Flammer Martina M.D.Chief Medical Officer
    INSMINSMED Inc
    Option exercise · 10b5-1 plan
    		M$346K
    18.3K sh
    		Aug 6, 2026Aug 7, 2026
    traded Aug 6, 2026
    		+1dSEC FORM 4

    Evidence

    6
    SA
    Smith Michael AlexanderChief Legal Officer
    INSMINSMED Inc
    Open-market sale · 10b5-1 plan
    		SELL$173K
    1,806 sh
    		Jun 22, 2026Jun 24, 2026
    traded Jun 22, 2026
    		+2dSEC FORM 4

    Evidence

    9
    BS
    Butera SamueleSVP, GM, Global Respiratory
    INSMINSMED Inc
    Grant or award
    		A—
    12.6K sh
    		Jun 23, 2026Jun 24, 2026
    traded Jun 23, 2026
    		+1dSEC FORM 4

    Evidence

    9
    BS
    Butera SamueleSVP, GM, Global Respiratory
    INSMINSMED Inc
    Grant or award
    		A—
    7,342 sh
    		Jun 23, 2026Jun 24, 2026
    traded Jun 23, 2026
    		+1dSEC FORM 4

    Evidence

    26
    SA
    Smith Michael AlexanderChief Legal Officer
    INSMINSMED Inc
    Open-market sale
    		SELL$221K
    2,159 sh
    		Jun 3, 2026Jun 5, 2026
    traded Jun 3, 2026
    		+2dSEC FORM 4

    Evidence

    24
    SA
    Smith Michael AlexanderChief Legal Officer
    INSMINSMED Inc
    Open-market sale
    		SELL$477K
    4,109 sh
    		May 13, 2026May 15, 2026
    traded May 13, 2026
    		+2dSEC FORM 4

    Evidence

    4
    SA
    Smith Michael AlexanderChief Legal Officer
    INSMINSMED Inc
    Option exercise · 10b5-1 plan
    		M—
    5,649 sh
    		Mar 30, 2026Mar 31, 2026
    traded Mar 30, 2026
    		+1dSEC FORM 4

    Evidence

    0
    SA
    Smith Michael AlexanderChief Legal Officer
    INSMINSMED Inc
    Option exercise · 10b5-1 plan
    		M$96K
    5,649 sh
    		Mar 30, 2026Mar 31, 2026
    traded Mar 30, 2026
    		+1dSEC FORM 4

    Evidence

    6
    SA
    Smith Michael AlexanderChief Legal Officer
    INSMINSMED Inc
    Option exercise · 10b5-1 plan
    		M$390K
    14.0K sh
    		Mar 30, 2026Mar 31, 2026
    traded Mar 30, 2026
    		+1dSEC FORM 4

    Evidence

    15
    SA
    Smith Michael AlexanderChief Legal Officer
    INSMINSMED Inc
    Open-market sale · 10b5-1 plan
    		SELL$2.96M
    19.6K sh
    		Mar 30, 2026Mar 31, 2026
    traded Mar 30, 2026
    		+1dSEC FORM 4

    Evidence

    4
    SA
    Smith Michael AlexanderChief Legal Officer
    INSMINSMED Inc
    Option exercise · 10b5-1 plan
    		M—
    14.0K sh
    		Mar 30, 2026Mar 31, 2026
    traded Mar 30, 2026
    		+1dSEC FORM 4

    Evidence

    6
    FD
    Flammer Martina M.D.Chief Medical Officer
    INSMINSMED Inc
    Open-market sale · 10b5-1 plan
    		SELL$132K
    869 sh
    		Feb 5, 2026Feb 6, 2026
    traded Feb 5, 2026
    		+1dSEC FORM 4

    Evidence

    22
    SA
    Smith Michael AlexanderChief Legal Officer
    INSMINSMED Inc
    Open-market sale
    		SELL$100K
    640 sh
    		Feb 3, 2026Feb 4, 2026
    traded Feb 3, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    House Periodic Transaction Report
    Publisher
    Clerk of the U.S. House of Representatives
    Document ID
    20034938

    Timestamps

    Event (reported)
    Jun 10, 2026
    Published
    Jul 7, 2026
    Ingested by INSIDER
    Nov 5, 00:34 UTC
    Last re-read
    Nov 5, 06:47 UTC

    Extracted facts

    Filer
    Josh Gottheimer
    Role
    JointAs filed: “JT”
    Transaction
    Partial saleAs filed: “S (partial)”
    Asset
    Insmed Incorporated - Common Stock
    Ticker
    INSM
    Reported value
    $1,001 – $15KAs filed: “$1,001 - $15,000”
    Execution date (reported)
    Jun 10, 2026
    Notification date (reported)
    Jul 7, 2026
    Days from execution to publication
    27

    Calculation

    Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.

    • Low: $1,001
    • High: $15,000

    = $8,001

    What this establishes

    Josh Gottheimer reported a partial sale of Insmed Incorporated - Common Stock (owner: joint). Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.

    Extraction

    Method
    PDF text extraction
    Confidence
    1.00
    Joint
    Josh Gottheimerbioguide:G000583
    Issuer
    INSMED Inccik:0001104506

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.